Rosalind Franklin University Gains $1.7M NIH Grant for Research
Rosalind Franklin University, a leader in medical research, has recently been awarded a substantial $1.7 million from the National Institutes of Health (NIH). This funding is specifically allocated to explore vital research into social recognition mechanisms related to schizophrenia and autism spectrum disorders.
The grant will support the work of Dr. Joanna Dabrowska, an accomplished neuroscientist at Rosalind Franklin University. She emphasizes that the focus will be on the neural circuits that underlie social recognition memory, a significant hurdle in understanding disorders like schizophrenia and autism spectrum disorder (ASD). The insights gained from this research could point to new avenues for therapeutic interventions.
In partnership with the Icahn School of Medicine at Mount Sinai (ISMMS), Dr. Dabrowska aims to further her study on oxytocin's role in regulating activity within the supramammillary nucleus in the hypothalamus. By understanding how this hormone influences social behaviors, the research may unveil methods to address social challenges faced by individuals with psychiatric disorders.
Dr. Dabrowska holds a prominent position as an associate professor in RFU's Center for Neurobiology of Stress Resilience and Psychiatric Disorders. She collaborates closely with fellow researcher Dr. Hala Harony-Nicolas from ISMMS as part of this pioneering project.
Dr. Dabrowska states, "Our project directly addresses critical gaps in our understanding of a neural circuit that supports social recognition. By defining how oxytocin modulates activity in the supramammillary nucleus of the hypothalamus, we hope to reveal mechanisms that could be harnessed to develop treatments for social deficits in psychiatric disorders." This statement reflects the innovative approach being taken in this research.
With her notable contributions to neuropsychiatry, Dr. Dabrowska has earned recognition as one of the Illinois Researchers to Know by the Illinois Science and Technology Coalition, spotlighting her impact on the field.
The NIH-funded study is titled "The Role of Oxytocin in Modulating Activity of the Supramammillary Nucleus (SuM) And Social Recognition Memory." It investigates the essential functions of oxytocin, known for facilitating social bonding, and its influence on key brain areas responsible for interpreting and recalling social interactions.
Schizophrenia, a long-term psychiatric disorder that disrupts thinking and social functions, affects nearly 2.5 million adults in the U.S. ASD, a developmental disorder that involves persistent social communication challenges, impacts about 1 in 36 children today. The challenges associated with social recognition can dramatically hinder the quality of life for individuals affected by these conditions, emphasizing the importance of this research.
RFU's Executive Vice President for Research, Joseph DiMario, PhD, commented on the significance of the collaboration, saying, "Dr. Dabrowska's leadership and this partnership with Mount Sinai represents an exciting opportunity for Rosalind Franklin University and the broader scientific community. We hope this research helps pave the way toward new therapeutic strategies for brain disorders with profound social deficits." His words highlight the optimism surrounding this endeavor.
About Rosalind Franklin University
Rosalind Franklin University of Medicine and Science is dedicated to advancing the spirit of inquiry exemplified by Dr. Rosalind Franklin, whose crucial work with DNA structure set the stage for modern genetics. The university has made significant strides in research across various fields, including neuroscience, metabolic disorders, and health science education.
To further its mission, RFU encompasses a diverse range of academic programs, including the Chicago Medical School, College of Nursing, and more, fostering a rich environment for learning and innovation. Visit their official site for more insights into their research initiatives and academic offerings.
For more inquiries, reach out to the Office of Marketing and Communications.
Frequently Asked Questions
What is the goal of the NIH-funded research at RFU?
The research aims to understand the neural mechanisms behind social recognition deficits in schizophrenia and autism spectrum disorder.
Who is leading the research project?
Dr. Joanna Dabrowska, a neuroscientist at RFU, is leading the research in collaboration with ISMMS.
What role does oxytocin play in this study?
Oxytocin is being studied for its effect on social memory and its potential use in therapeutic strategies for social deficits in psychiatric disorders.
Why is this research important?
Understanding social recognition mechanisms could lead to new treatments for conditions that significantly impair social functioning and quality of life.
How does this research contribute to the scientific community?
The findings may provide new insights and therapeutic avenues for managing social deficits in individuals with mental health challenges.
